Munger Mode rating: 2 out of 5 — Sell. Our own rating from the research report below, on business quality first: moat durability and management, with price separating the top three.
Price used: about $216 (October 22, 2026 close of $216.64; quote sites differ by a few dollars). Market capitalization is roughly $11.3 billion on 52.2 million shares. We start with what we can see in the filing, because the numbers are blunt. In the first nine months of 2026, Molina earned $112 million of net income on $32.8 billion of revenue, a margin of 0.3%. A year earlier it earned $632 million. The stock still sells for about 41 times the company's own full-year adjusted earnings floor of "at least $5.25," and for about 23 times the "more than $9.50" that management says it can build toward in 2027. Managed Medicaid is a necessary service, and Molina is a competent operator in it.
Recent filings analysed: 8-K (2026-11-06), 10-Q (2026-10-22), 8-K (2026-10-21), 10-Q (2026-07-23).
Stock screener · Superinvestor 13F holdings · Analyst sentiment